News
A landmark review, now published in the Journal of Experimental & Clinical Cancer Research, offers a sweeping and ...
The firm announced deals with UMass Chan Medical School and Quiver to further its ambitions to develop transformative treatments for the condition.
QurAlis' FlexASO® platform was developed to generate splice-switching ASOs with improved potency, increased therapeutic index and improved bio-distribution. This bespoke platform has the potential to ...
Researchers have created a new kind of nanoparticle that could make ultrasound-based cancer treatments more effective and ...
The results of an international study led by researchers from Queen Mary University of London’s Precision Healthcare University Research Institute (PHURI) shed new light the underlying biological ...
To more effectively treat neurodegenerative conditions, we first need diagnostic tools that lend a more complete picture of ...
The results of an international study shed new light the underlying biological mechanisms which cause differences in health risks, symptoms and outcomes between males and females.
Leading cancer researchers from UC San Francisco presented talks about advances in targeted therapies, cancer genomics, using AI to personalize cancer treatment, improving diagnosis of hard-to-treat ...
The efforts of a research team give hope for new treatment approaches for dangerous tropical diseases. The researchers have compiled a high-precision inventory of the membrane proteins of cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results